124 related articles for article (PubMed ID: 22414730)
1. The abnormal processing of TDP-43 is not an upstream event of reduced ADAR2 activity in ALS motor neurons.
Yamashita T; Hideyama T; Teramoto S; Kwak S
Neurosci Res; 2012 Jun; 73(2):153-60. PubMed ID: 22414730
[TBL] [Abstract][Full Text] [Related]
2. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2.
Aizawa H; Sawada J; Hideyama T; Yamashita T; Katayama T; Hasebe N; Kimura T; Yahara O; Kwak S
Acta Neuropathol; 2010 Jul; 120(1):75-84. PubMed ID: 20372915
[TBL] [Abstract][Full Text] [Related]
4. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
[TBL] [Abstract][Full Text] [Related]
5. [Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].
Kwak S
Brain Nerve; 2012 May; 64(5):549-56. PubMed ID: 22570068
[TBL] [Abstract][Full Text] [Related]
6. Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.
Yamashita T; Kwak S
Neurosci Res; 2019 Jul; 144():4-13. PubMed ID: 29944911
[TBL] [Abstract][Full Text] [Related]
7. Co-occurrence of TDP-43 mislocalization with reduced activity of an RNA editing enzyme, ADAR2, in aged mouse motor neurons.
Hideyama T; Teramoto S; Hachiga K; Yamashita T; Kwak S
PLoS One; 2012; 7(8):e43469. PubMed ID: 22916266
[TBL] [Abstract][Full Text] [Related]
8. Autophagy in spinal motor neurons of conditional ADAR2-knockout mice: An implication for a role of calcium in increased autophagy flux in ALS.
Sasaki S; Yamashita T; Kwak S
Neurosci Lett; 2015 Jun; 598():79-84. PubMed ID: 25980994
[TBL] [Abstract][Full Text] [Related]
9. ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.
Hosaka T; Yamashita T; Teramoto S; Hirose N; Tamaoka A; Kwak S
Neurosci Res; 2019 Oct; 147():48-57. PubMed ID: 30448461
[TBL] [Abstract][Full Text] [Related]
10. Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.
Aizawa H; Hideyama T; Yamashita T; Kimura T; Suzuki N; Aoki M; Kwak S
J Clin Neurosci; 2016 Oct; 32():128-9. PubMed ID: 27343041
[TBL] [Abstract][Full Text] [Related]
11. [Calpain plays a crucial role in TDP-43 pathology].
Yamashita T; Kwak S
Rinsho Shinkeigaku; 2014; 54(12):1151-4. PubMed ID: 25672733
[TBL] [Abstract][Full Text] [Related]
12. AMPA receptor-mediated neuronal death in sporadic ALS.
Kwak S; Hideyama T; Yamashita T; Aizawa H
Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521
[TBL] [Abstract][Full Text] [Related]
13. Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis.
Yamashita T; Akamatsu M; Kwak S
Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28208729
[TBL] [Abstract][Full Text] [Related]
14. Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons.
Yamashita T; Chai HL; Teramoto S; Tsuji S; Shimazaki K; Muramatsu S; Kwak S
EMBO Mol Med; 2013 Nov; 5(11):1710-9. PubMed ID: 24115583
[TBL] [Abstract][Full Text] [Related]
15. Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis.
Hideyama T; Yamashita T; Nishimoto Y; Suzuki T; Kwak S
J Pharmacol Sci; 2010; 113(1):9-13. PubMed ID: 20424386
[TBL] [Abstract][Full Text] [Related]
16. Pathological features of glial cells and motor neurons in the anterior horn of the spinal cord in sporadic ALS using ADAR2 conditional knockout mice.
Naito M; Hideyama T; Teramoto S; Saito T; Kato H; Terashi H; Kwak S; Aizawa H
J Neurol Sci; 2023 Jan; 444():120520. PubMed ID: 36527980
[TBL] [Abstract][Full Text] [Related]
17. A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology.
Yamashita T; Hideyama T; Hachiga K; Teramoto S; Takano J; Iwata N; Saido TC; Kwak S
Nat Commun; 2012; 3():1307. PubMed ID: 23250437
[TBL] [Abstract][Full Text] [Related]
18. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
[TBL] [Abstract][Full Text] [Related]
19. Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons.
Yamashita T; Aizawa H; Teramoto S; Akamatsu M; Kwak S
Sci Rep; 2017 Jan; 7():39994. PubMed ID: 28045133
[TBL] [Abstract][Full Text] [Related]
20. Unique nuclear vacuoles in the motor neurons of conditional ADAR2-knockout mice.
Sasaki S; Takenari Yamashita ; Hideyama T; Kwak S
Brain Res; 2014 Mar; 1550():36-46. PubMed ID: 24440630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
